JERSEY CITY, Nov. 3, 2011 /PRNewswire-Asia-First Call/ --
American Oriental Bioengineering, Inc. (NYSE: AOB), ("the Company"
or "AOBO"), a pharmaceutical company dedicated to improving health
through the development, manufacture and commercialization of a
broad range of prescription and over the counter ("OTC") products,
today announced that it plans to release third quarter 2011
financial results on Tuesday, November 8,
2011, after the market closes.
The Company will hold a conference call at 8:00 am ET on Wednesday,
November 9, 2011, to discuss its results. Listeners may
access the call by dialing 1-800-706-7748 or 1-617-614-3473 for
international callers, access code: 12956598.
A replay of the call will be available through November 16, 2011. Listeners may access the
replay by dialing 1-888-286-8010 or 1-617-801-6888 for
international callers, access code: 34707830.
About American Oriental Bioengineering, Inc.
American Oriental Bioengineering, Inc. is a pharmaceutical
company dedicated to improving health through the development,
manufacture and commercialization of a broad range of prescription
and over the counter products.
Safe Harbor Statement
Statements made in this press release are forward-looking and
are made pursuant to the safe harbor provisions of the Securities
Litigation Reform Act of 1995. Such statements involve risks and
uncertainties that may cause actual results to differ materially
from those set forth in these statements. The economic,
competitive, governmental, technological and other factors
identified in the Company's filings with the Securities and
Exchange Commission, may cause actual results or events to differ
materially from those described in the forward looking statements
in this press release. The Company undertakes no obligation to
publicly update or revise any forward-looking statements, whether
because of new information, future events, or otherwise.
Contact:
American Oriental Bioengineering, Inc.
Hong Zhu
1-646--367-1765
SOURCE American Oriental Bioengineering, Inc.